Header Logo

Connection

RUSSELL BROADDUS to Boron Compounds

Back to Details
This is a "connection" page, showing publications RUSSELL BROADDUS has written about Boron Compounds.
RUSSELL BROADDUS
Connection Strength
0.167
Boron Compounds
  1. Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies. Sci Rep. 2020 02 20; 10(1):3080.
    View in: PubMed
    Score: 0.167
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.